The role of antiglycolipid antibodies in peripheral neuropathies

Current Opinion in Neurology

Volumn 13, Issue 5, 2000, Pages 583-588

  O'Leary, Colin P ^a   Willison, Hugh J ^a,b  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOLIPID ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; DEMYELINATING DISEASE; GUILLAIN BARRE SYNDROME; HUMAN; MOTOR NEUROPATHY; PARAPROTEINEMIA; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHENOTYPE; SUBCLAVIAN STEAL SYNDROME;

ANTIBODIES; GANGLIOSIDES; GLYCOLIPIDS; HUMANS; PARAPROTEINEMIAS; PERIPHERAL NERVOUS SYSTEM DISEASES; PHENOTYPE;

EID: 0033791310     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200010000-00013     Document Type: Article

References (53)

1. Autoantibodies associated with peripheral neuropathy
2. Facts and fallacies on anti-GM1 antibodies: Physiology of motor neuropathies
3. The immunopathogenesis of Miller Fisher syndrome
4. Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies
5. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barre syndrome
6. Anti-GalNAc-GD1a antibody-associated Guillain-Barre syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance
7. Rapidly progressive, predominantly motor Guillain-Barre syndrome with anti-GalNAc-GD1a antibodies
8. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barre syndrome after Campylobacter jejuni enteritis
9. Autoantibodies to GM1b and GalNAc-GD1a: Relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China
10. Hyperreflexia in Guillain-Barre syndrome: Relation with acute motor axonal neuropathy and anti-GM1 antibody
11. Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis-Sumner syndrome
12. Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy
13. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia
14. IgG anti-GQ1b positive acute ataxia without ophthalmoplegia
15. Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis
16. Bilateral ballism in a patient with overlapping Fisher's and Guillain-Barre syndromes
17. Antiganglioside antibody in patients with Guillain Barre syndrome who show bulbar palsy as an initial symptom
18. Oropharyngeal palsy in Guillain-Barre and Fisher's syndromes is associated with muscle weakness in the neck and arm
19. Long-term clinical and neurophysiological follow-up of patients with peripheral neuropathy associated with benign monoclonal gammopathy
20. Prognosis of neuropathy with monoclonal gammopathy
21. Sensorimotor polyneuropathy associated with chronic lymphocytic leukaemia, IgM antigangliosides antibody and human T-cell leukaemia virus I infection
22. Clinicopathological study of an autopsy case with sensory-dominant polyradiculoneuropathy with antiganglioside antibobodies
23. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barre syndrome
24. Are Campylobacter curvus and Campylobacter upsaliensis antecedent infectious agents in Guillain-Barre and Fisher's syndromes?
25. Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barre syndrome
26. Haemophilus influenzae has a GM1 gangliosidelike structure and elicits Guillain-Barre syndrome
27. Acute motor axonal neuropathy with anti-GM1 following Mycoplasma pneumoniae infection
28. Antiganglioside antibodies in Guillain-Barre syndrome after a recent cytomegalovirus infection
29. Cytomegalovirus is not associated with IgM anti-myelin-associated glycoprotein/sulphate-3-glucuronyl paragloboside antibody-associated neuropathy
30. Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection
31. Recurrent Miller Fisher syndrome: Clinical and laboratory features and HLA antigens
32. Schmidt-Lanterman's incisures: The principal target of autoimmune attack in demyelinating Guillain-Barre syndrome?
33. The distribution of ganglioside-like moieties in peripheral nerves
34. Degeneration of rabbit sensory neurons induced by passive transfer of anti-GD1b antiserum
35. Rabbit experimental sensory ataxic neuropathy: Anti-GD1b antibody-mediated trkC downregulation of dorsal root ganglia neurons
36. Axonal involvement at the common entrapment sites in Guillain-Barre syndrome with IgG anti-GM1 antibody
37. Fisher syndrome with tetraparesis and antibody to GQ1b: Evidence for motor nerve terminal block
38. Miller Fisher anti-GQ1b antibodies: α-latrotoxin-like effects on motor end plates
39. Monoclonal antibodies raised against Guillain-Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations
40. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro
41. Myelinated dorsal root ganglion cultures activate both the alternate and classical pathways of complement
42. Immune-mediated peripheral neuropathies and voltage-gated sodium channels
43. Anti-GM2 IgM antibodies: Clinical correlates and reactivity with a human neuroblastoma cell line
44. Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barre syndrome
45. Antibodies to GD1alpha and to GQ1beta in Guillain-Barre syndrome and the related disorders
46. Antibodies to GD3, GT3, and O-acetylated species in Guillain-Barre and Fisher's syndromes: Their association with cranial nerve dysfunction
47. Chronic motor neuropathies: Response to interferon-beta 1a after failure of conventional therapies
48. Use of human intravenous immunoglobulin in lower motor neuron syndromes
49. Successful treatment of IgM paraproteinaemic neuropathy with fludarabine
50. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab
51. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinaemia
52. Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies
53. Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy